Tag Archives: Health Canada

Featured Stories

FDA Advisors Set to Examine Metal-on-Metal Hip Implant Safety Concerns

Thousands of people with metal-on-metal hip implant devices could soon get some answers from the U.S. Food & Drug Administration (FDA) about the dangers they face. Tomorrow, the agency will convene a panel of outside medical experts to examine the safety record of metal-on-metal hip replacements, and recommend the ...

Read More

Death in Those Taking Bactrim with ACE Inhibitors or ARBs

Sudden Death in Those Taking Bactrim Along with ACE Inhibitors or ARBs

Association between sudden death in those given Bactrim while already taking renin-angiotensin system blockers angiotensin receptor blockers (ARBs), heart medications.

Read More

Johnson & Johnson’s Ethicon Division to End Sales of Gynecare Prolift, Three Other Transvaginal Mesh Devices

Johnson & Johnson’s Ethicon Inc. division revealed yesterday that it will end sales of its Gynecare Prolift device and three other transvaginal mesh products. The plan to stop selling the four products was set forth in a letter filed by the company in the Ethicon transvaginal mesh multidistrict litigation ...

Read More

DePuy ASR Hip Implants, Other Faulty Medical Devices Subject to Little FDA Oversight, Investigation Finds

A newly-published investigation from ProPublica has revealed that several questionable types of medical devices, including DePuy Orthopaedic’s recalled ASR hip implant, managed to make it to market without much scrutiny on the part of the U.S. Food & Drug Administration (FDA).

Read More

Lawsuit Alleges Bi-Lateral DePuy ASR Hip Implant Resulted in Elevated Chromium and Cobalt Levels, Need for Revision Surgery

DePuy Orthopaedics and its parent, Johnson & Johnson, continue to be named in lawsuits by metal-on-metal hip replacement recipients who suffered severe injuries, including elevated chromium and cobalt levels, allegedly due to recalled ASR hip implant devices. Most recently, the national law firm of Parker Waichman LLP filed suit on ...

Read More

New Study Links Metal-on-Metal Hip Replacement Corrosion with Adverse Local Tissue Reactions

Yet another study is pointing to potential dangers posed by metal-on-metal hip implants. This time, an article published in the Journal of Arthroplasty is reporting corrosion in the head taper junction was more likely to occur in patients with 36-mm diameter metal-on-metal hip replacement, compared to those with the same ...

Read More

New York City Council Calls for Zadroga Act to be Renewed

New York City Council Calls for Zadroga Act to be Renewed

New York City Council members are calling for the Zadroga Act, which provides compensation and medical treatment to 9/11 victims, to be renewed. According to press release issued Jan. 7, a resolution was introduced by Council Member Margaret Chin, Council Speaker Melissa Mark-Viverito and Council Members Paul Vallone and I. ...

Read More

West Virginia Man Claims Metal-on-Metal DePuy Pinnacle Hip Replacement Led to Pain, Elevated Cobalt Levels

A West Virginia man fitted with a metal-on-metal version of DePuy Orthopaedics’ Pinnacle Hip Implant System has filed suit against the company and its parent, Johnson & Johnson, alleging the device caused him to suffer pain and elevated cobalt levels. The Plaintiff is being represented by the national law ...

Read More

Birth Control Shot Depo-Provera may Increase HIV Risk

Birth Control Shot Depo-Provera may Increase HIV Risk, Study Suggests

A new study has linked the use of Depo-Provera (medroxyprogesterone acetate), an injectable type of birth control, to an increased risk of HIV infection.

Read More

Study Finds SSRI Antidepressant Side Effects Outweigh Their Benefits

A new study is raising more concerns about the safety of commonly used antidepressants, including selective serotonin reuptake (SSRI) inhibitor antidepressants. Investigators who conducted the study, which is published in the journal Frontiers in Psychology, posit that increased knowledge of the negative effects of SSRIs and other antidepressants could reduce ...

Read More

Stryker Recalls Metal Hip Implant Component in Canada

Stryker Recalls Metal Hip Implant Component in Canada

Stryker Orthopaedics may be facing a new wave of litigation over a recently recalled metal hip implant component. The Stryker LFIT CoCr V40 femoral heads were recalled in Canada. According to an Aug. 24, 2016 recall alert posted on Health … Continue reading

Posted in Defective Medical Devices, Metal Hip Implants | Tagged , , , , |

Health Canada Warns of Complications with IVC Filters

Health Canada Warns of Complications with IVC Filters

Health Canada has issued a safety alert regarding the use of inferior vena cava (IVC) filters, which are used to stop blood clots from reaching the heart or lungs. The regulators warned that patients receiving IVC filters have reported serious … Continue reading

Posted in Bard IVC Filter Injuries, Defective Medical Devices | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |

Health Canada Warns of Birth-Defect and Miscarriage Potential for Transplant Anti-rejection Drugs

CellCept

Canada’s health regulatory agency has issued a warning that CellCept (mycophenolate mofetil) and Myfortic (mycophenolate sodium), drugs given to prevent organ rejection in transplant patients, can cause miscarriage and congenital malformations if taken during pregnancy. The agency warns against using … Continue reading

Posted in Birth Defects, Health Concerns, Pharmaceuticals | Tagged , , , , |

Health Canada Strengthens Safety Warnings for Multiple Sclerosis Drug Gilenya

Health Canada Strengthens Safety Warnings for Drug Gilenya

Health Canada, Canada’s health regulatory agency, has updated the label information for the multiple sclerosis drug Gilenya (fingolimod) to include stronger safety warnings on the risk of skin cancer and the rare brain infection progressive multifocal leukoencephalopathy (PML), which can … Continue reading

Posted in Gilenya, Health Concerns, Pharmaceuticals | Tagged , , , , |

Health Canada Warns that Skin-Cancer Drug Zelboraf Carries Risk of Pancreatitis

Health Canada Warns Zelboraf Carries Risk of Pancreatitis

The skin-cancer drug Zelboraf (vemurafenib) is associated with a risk of pancreatitis, Health Canada warns. According to a safety alert posted on the regulator’s website Thursday, the drug’s prescribing information has been updated to reflect this risk. Zelboraf is used … Continue reading

Posted in Legal News | Tagged , , , , , |

© 2005-2019 Parker Waichman LLP ®. All Rights Reserved.